| NDC Code | 68682-409-10 |
|---|
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (68682-409-10) |
|---|
| Product NDC | 68682-409 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Chlordiazepoxide Hydrochloride And Clidinium Bromide |
|---|
| Non-Proprietary Name | Chlordiazepoxide Hydrochloride And Clidinium Bromide |
|---|
| Dosage Form | CAPSULE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20090923 |
|---|
| End Marketing Date | 20190228 |
|---|
| Marketing Category Name | NDA AUTHORIZED GENERIC |
|---|
| Application Number | NDA012750 |
|---|
| Manufacturer | Oceanside Pharmaceuticals |
|---|
| Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
|---|
| Strength | 5; 2.5 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Benzodiazepine [EPC],Benzodiazepines [CS],Anticholinergic [EPC],Decreased Parasympathetic Acetylcholine Activity [PE],GI Motility Alteration [PE],Digestive/GI System Activity Alteration [PE],Cholinergic Antagonists [MoA] |
|---|